These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2306576)

  • 1. When a patient with known lupus nephritis has persistent proteinuria despite corticosteroids and immunosuppressive treatment can it be assumed that there is continuing disease activity or may it reflect irreparable glomerular damage? How can one be sure?
    Cameron JS
    Br J Rheumatol; 1990 Feb; 29(1):68. PubMed ID: 2306576
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lupus nephropathy in children].
    Fischbach M
    Arch Pediatr; 2010 Jun; 17(6):628-9. PubMed ID: 20654813
    [No Abstract]   [Full Text] [Related]  

  • 3. Lupus Nephritis.
    Wenderfer SE; Eldin KW
    Pediatr Clin North Am; 2019 Feb; 66(1):87-99. PubMed ID: 30454753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.
    Fiehn C; Hajjar Y; Mueller K; Waldherr R; Ho AD; Andrassy K
    Ann Rheum Dis; 2003 May; 62(5):435-9. PubMed ID: 12695156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of nephritis in systemic lupus erythematodes].
    Ligtenberg G; Derksen RH; Berden JH
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we manage lupus nephritis without chronic corticosteroids administration?
    Lightstone L; Doria A; Wilson H; Ward FL; Larosa M; Bargman JM
    Autoimmun Rev; 2018 Jan; 17(1):4-10. PubMed ID: 29108828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus nephropathy: difficulties in its treatment].
    Flores JC
    Rev Med Chil; 1989 Aug; 117(8):930-6. PubMed ID: 2519456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
    Tse KC; Lam MF; Tang SC; Tang CS; Chan TM
    Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis.
    Gao JJ; Cai GY; Liu SW; Tang L; Zhang XG; Yang Y; Chen P; Liu SX; Ji JY; Shi SZ; Yin Z; Chen XM
    Rheumatol Int; 2012 Jun; 32(6):1751-9. PubMed ID: 21442167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term outcomes and histological transformation in class II lupus nephritis.
    Alsuwaida AO; Bakhit AA; Alsuwaida FA; Wadera JJ; Kfoury HM; Husain S
    Saudi Med J; 2018 Oct; 39(10):990-993. PubMed ID: 30284580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal involvement in systemic lupus erythematosus].
    Karras A
    Presse Med; 2012 Mar; 41(3 Pt 1):260-6. PubMed ID: 22192934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current role for clinical and renal histological findings as predictor for outcome in Australian patients with lupus nephritis.
    Nossent J; Raymond W; Kang A; Wong D; Ognjenovic M; Chakera A
    Lupus; 2018 Oct; 27(11):1838-1846. PubMed ID: 30092734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
    Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
    Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphologically unfavorable forms of lupus glomerulonephritis: treatment and prognosis].
    Zakharova EV; Mikhaĭlova NA; Ermolenko VM; Gabdurakhmanov II; Varshavskiĭ VA; Proskurneva EP
    Ter Arkh; 2003; 75(6):56-60. PubMed ID: 12920962
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroids in Lupus Nephritis and Central Nervous System Lupus.
    Kamen DL; Zollars ES
    Rheum Dis Clin North Am; 2016 Feb; 42(1):63-73, viii. PubMed ID: 26611551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C; Izumino K; Iida H; Fujita M; Asaka M; Takata M; Sasayama S
    Nephron; 1993; 64(3):471-5. PubMed ID: 7688103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclophosphamide or azathioprine on urinary podocytes in patients with diffuse proliferative lupus nephritis.
    Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
    Nephron; 2001 Feb; 87(2):192-3. PubMed ID: 11244319
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematuria in a patient with class IV lupus nephritis.
    Mittal BV; Pendse S; Rennke HG; Singh AK
    Kidney Int; 2006 Sep; 70(6):1182-6. PubMed ID: 16871238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lupus patient with nephropathy. Survival is kidney problem].
    MMW Fortschr Med; 2008 Jan; 150(5):17. PubMed ID: 18300547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.